DRC approves compassionate use of investigational Ebola treatments

A Democratic Republic of the Congo ethics committee approved the use of five investigational Ebola therapies under compassionate use and expanded access.

The World Health Organization said four of the five approved products are in the country: Zmapp from Mapp

Read the full 392 word article

User Sign In